A Randomised, Evaluator-Blinded, Two-Arm Study To Evaluate The Safety And Efficacy of a Novel Microneedle and Laser-Based Medical Device For The Treatment of Androgenetic Alopecia in Adult Males
The purpose of this 24-week study is to see if the SAGA-001 device is safe and effective at helping people with male pattern hair loss.
Two different device configurations are being explored as part of this study. Device A has novel microneedles, lasers, and additional metal microneedles, while Device B only has novel microneedles and lasers.
Participants will receive 12 treatments with either Device A or Device B over the course of 24 weeks. Treatments will be performed on-site every two weeks.
100 Clinical Results associated with StimuSIL Inc.
0 Patents (Medical) associated with StimuSIL Inc.
100 Deals associated with StimuSIL Inc.
100 Translational Medicine associated with StimuSIL Inc.